FenoMark develops and commercializes tools that enables next generation molecular testing.
FenoMark Diagnostics AB has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
FenoMark Diagnostics AB is headquartered in Stockholm, Sweden.
FenoMark develops and commercializes tools that enables next generation molecular testing.
FenoMark Diagnostics AB is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"FenoMark Diagnostics AB — Funding & Investors." VCBacked, December 16, 2025, https://www.vcbacked.co/company/fenomark-diagnostics-ab. Accessed September 30, 2026.
VCBacked. (2025). FenoMark Diagnostics AB — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/fenomark-diagnostics-ab
{{cite web |title=FenoMark Diagnostics AB — Funding & Investors |url=https://www.vcbacked.co/company/fenomark-diagnostics-ab |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated